Skip to main content
. 2021 Aug 3;12(12):2212–2220. doi: 10.1111/jdi.13606

Table 2.

Relevant data of plasma glucose levels and GAP

Survivors

(n = 310)

Nonsurvivors

(n = 192)

All patients (n = 502) P value
BG at admission (mmol/L) 10.2 (7.7, 13.8) 11.9 (9.0, 15.0) 10.8 (8.2,14.3) 0.002*
MGL (mmol/L) 10.5 ± 3.1 12.7 ± 2.4 11.6 (9.4,13.3) <0.001*
SD (mmol/L) 2.6 (1.9, 3.5) 3.9 ± 1.5 2.9 (2.1, 4.1) <0.001*
CV (%) 25.7 (20.3, 33.3) 30.7 ± 10.4 27.6 (21.2, 34.9) <0.001*
HbA1c (mmol/L) 6.9 (6.1,7.9) 7.0 (6.2, 7.8) 6.9 (6.2,7.9) 0.763
ADAG (mmol/L) 8.4 (7.1, 10.0) 8.6 (7.3, 9.8) 8.4 (7.3, 10.0) 0.784
GAPadm (mmol/L) 1.8 (−0.6,4.4) 3.3 (0.9, 6.3) 2.3 (−0.2, 5.3) <0.001*
GAPmean (mmol/L) 2.4 (−0.1, 3.5) 4.2 (3.7, 5.0) 3.3 (1.2, 4.2) <0.001*
MH, n (%) 14 (4.5) 45 (23.4) 59 (11.8) <0.001*
SH, n (%) 4 (1.3) 21 (10.9) 25 (5.0) <0.001*
*

P < 0.05. ADAG, A1C‐derived average glucose; BG, blood glucose; GAPadm, glycemic gap between blood glucose at admission and ADAG; GAPmean, glycemic gap between MGL and ADAG; MGL, mean glucose level; MH, moderate hypoglycemia, blood glucose: 2.2–3.3 mmol/L; SH, severe hypoglycemia, blood glucose:<2.2 mmol/L.